29.01.2013 • News

Oxea Announces Sales Control on Intermediates in the Americas

Effective immediately Oxea will implement a 100% sales control in North and South America

The following Intermediates line products effective until further notice.

n-Propanol

n-Butanol

n-Propyl Acetate

n-Butyl Acetate

The sales control will be based on the average monthly consumption over the last 6 months or as allowed by contract.

Company

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.